期刊文献+

干细胞在慢性阻塞性肺疾病中的研究进展 被引量:1

下载PDF
导出
摘要 慢性阻塞性肺病(chronicobstructivepulmona—rydisease,COPD)是一种具有气流受限不完全可逆,呈进行性发展的气道炎症反应性疾病。该病的患病率和死亡率有逐年上升的趋势。传统的药物及相关外科治疗均不能阻止病情的进一步发展,作用非常有限。最近关于间充质干细胞(mesenchymalstemcells,MScs)对肺损伤的研究逐渐开展起来,本文综述了MSCs以及COPD和其模型的特征,并着重阐述了关于MSCs对损伤肺组织的修复作用以及可能存在的修复机制研究,并探讨近年来MSCs在COPD上的临床应用,从而为肺组织损伤的修复和再生带来新的希望。
出处 《右江医学》 2012年第3期408-412,共5页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献38

  • 1Hashemi SM,Ghods S, Kolodgie FD, et al. A placebo con- trolled,does-ranging, safety study of allogenic mesenchy- mal stem cells injected by endo-myocardial delivery after an acute myocardial infarction[J]. Eur Heart J, 2008,29 (2) :251-259.
  • 2Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary [J]. Am J Respir Crit Care Med, 2007,176 (6) : 532-555.
  • 3iGross P, Pfitzer EA, Tolker E, et al. Experimental em- physema:its production with papain in normal and silicot- ic rats[J]. Health,1965(11) :50-58.
  • 4Tayyareci Y,Umman B,Sezer M, et al. Intracoronary au- tologous bone marrow-derived stem cell transplantation in patients with ischemic myocardiopathy., results of 18- month follow-up[J]. Turk Kardiyol Dern Ars, 2008, 36 (8) :519-529.
  • 5Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/ progenitor cells and stern-cell transplantation for the treatment of liver disease[J]. J Gastroenterol, 2009, 44 (3) :167-172.
  • 6ltoh T, Satou T, lshida H, et al. The relationship between SDF-I alpha/CXCR4 and neural stem cells appearing in damaged area after traumatic brain injury in rats[J]. Neu- rol Res,2009,31(1) :90-102.
  • 7Larghero J, Vija L, Lecourt S, et al. Mesenchymal stem cells and immunomodulation: Toward new immunosup- pressive strategies for the treatment of autoimmune dis- eases[J]. Rev Med Interne,2009,30(3):287-299.
  • 8Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects [J]. Proc Natl Acad Sci USA, 2003,100(14): 8407-8411.
  • 9Fischer UM, Harting MT, Jlmenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell de- livery:The pulmonary first pass effect[J].Stem Cells, 2009,18 (5) : 683-692.
  • 10Aliotta JM, Keaney P, Passero M, et al. Bone marrow production of lung eells the impact of G-CSF, cardio- toxin, graded doses of irradiation, and subpopulation phenotype[J]. Exp Haematol, 2006,34 (2) : 230-241.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部